Review Article

Long Noncoding RNAs as Biomarkers in Cancer

Table 1

Upregulated cancer-associated lncRNAs when compared to normal tissues.

NameCancer typeFold changeaReferences

Wt1-asAcute myeloid leukemiaNAb[111]
XISTGliomaNA[112]
CRNDEGliomaNA[113]
MALAT1Glioma2.0–5.0[114]
Colorectal2.0–6.0[115]
Lung>40.0[116]
ProstateNA[84]
HepatocellularNA[117]
UterusNA[118]
LSINCT5Breast2.0–7.0[119]
LINC00617Breast>1.5[120]
RP11-445H22.4Breast15.0–20.0[121]
BC200BreastNA[122]
CCHE1CervicalNA[123]
CCAT1-LColorectalNA[71]
POU3F3EsophagealNA[124]
PCAT-1ColorectalNA[125]
ProstateNA[126]
HOTAIREsophagealNA[127]
LungNA[128]
CervicalNA[129]
PancreasNA[130]
BreastNA[52]
OralNA[131]
Hepatocellular>2.0[132]
GliomaNA[133, 134]
Colorectal5.2[101]
CCAT2Lung7.5[135]
ColonNA[136]
CervicalNA[137]
LINC00152GastricNA[35, 90]
LSINCT-5GastricNA[138]
HOXA11-ASGliomaNA[139]
Linc-POU3F3Glioma>2.6[140]
ATBGlioma5.0–10.0[141]
AB073614GliomaNA[142]
RP11-160H22.5Hepatocellular2.5[109]
XLOC_014172Hepatocellular67.7[109]
LOC149086Hepatocellular4.6[109]
BANCRHepatocellularNA[143]
SNHG3HepatocellularNA[144]
MVIHHepatocellular3.75[145]
LungNA[146]
LCAL1LungNA[147]
LUADT1LungNA[148]
AFAP1-AS1LungNA[149]
ColorectalNA[150]
HepatocellularNA[151]
Esophageal>1.0[152]
ANRILLung>1.5[153]
Hepatocellular>1.0[154]
Bladder>1.0[155]
UCA1LungNA[156]
OralNA[157]
Bladder32.9[158]
ColonNA[159]
HepatocellularNA[160]
BreastNA[161]
Esophageal>2.0[162]
CASC15MelanomaNA[163]
SPRY4-IT1Melanoma>2.0[164, 165]
GliomaNA[166]
H19BladderNA[167]
GastricNA[83]
EsophagealNA[168]
ColorectalNA[169]
GliomaNA[170]
HULCPancreasNA[171]
Hepatocellular32.7[102]
GliomaNA[172]
PCA3ProstateNA[34, 99]
PCAT5ProstateNA[173]
PCAT18Prostate8.8–11.1[174]
PRNCR1ProstateNA[175]
NEAT1GliomaNA[176, 177]
OralNA[74]
HepatocellularNA[178]
NasopharyngealNA[179]
PVT1ThyroidNA[180]
GastricNA[181]
ColorectalNA[182]
SRABreastNA[183]

aFold change values, relative to normal controls; bnot available (data is presented in a graphical format in the original report).